MOLEBRIDGE PRACTICE
3 CANNONSIDE, FETCHAM, LEATHERHEADCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 188 | 231 | 81.4% | |
CHD 9 | 2006 | 211 | 233 | 90.6% | |
CHD 9 | 2007 | 209 | 226 | 92.5% | |
CHD 9 | 2008 | 212 | 229 | 92.6% | |
CHD 9 | 2009 | 202 | 222 | 91.0% | |
CHD 9 | 2010 | 205 | 220 | 93.2% | |
CHD 9 | 2011 | 203 | 218 | 93.1% | |
CHD 9 | 2012 | 202 | 221 | 91.4% | |
CHD 9 | 2013 | 201 | 221 | 91.0% | |
CHD005 | 2014 | 202 | 207 | 97.6% | |
CHD005 | 2015 | 196 | 201 | 97.5% | |
CHD005 | 2016 | 186 | 191 | 97.4% | |
CHD005 | 2017 | 162 | 168 | 96.4% | |
CHD005 | 2018 | 154 | 160 | 96.2% | |
CHD005 | 2019 | 136 | 139 | 97.8% | |
CHD005 | 2020 | 142 | 144 | 98.6% | |
CHD005 | 2021 | 148 | 164 | 90.2% | |
CHD005 | 2022 | 151 | 160 | 94.4% | |
CHD005 | 2023 | 166 | 169 | 98.2% |